Kiromic BioPharma Inc. (KRBP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kiromic BioPharma Inc.

    OTC: KRBP · Real-Time Price · USD
    0.20
    0.00 (0.05%)
    At close: Mar 24, 2025, 3:59 PM

    Kiromic BioPharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 2.8M 2.07M 469.8K
    Gross Profit
    		 n/a -2.8M -2.07M -469.8K
    Operating Income
    		 -23.77M -19.94M -31.11M -25.74M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -26.9M -20.95M -34.73M -25.59M
    Net Income
    		 -26.9M -21.29M -38.18M -25.65M
    Selling & General & Admin
    		 8.85M 7.52M 17.19M 13.94M
    Research & Development
    		 6.85M 9.62M 13.92M 11.37M
    Other Expenses
    		 8.07M n/a n/a 53.4K
    Operating Expenses
    		 23.77M 17.14M 31.11M 25.31M
    Interest Expense
    		 -3.72M -1.85M 166.5K 12.2K
    Selling & Marketing Expenses
    		 n/a -2.8M n/a n/a
    Cost & Expenses
    		 n/a 19.94M 31.11M 25.31M
    Income Tax Expense
    		 n/a n/a 3.45M 65.6K
    Shares Outstanding (Basic)
    		 26.07M 32.93M 16.34M 11.42M
    Shares Outstanding (Diluted)
    		 26.07M 32.93M 16.34M 11.42M
    EPS (Basic)
    		 -1.03 -21.41 -70.12 -67.4
    EPS (Diluted)
    		 -1.03 -21.41 -70.12 -67.4
    EBITDA
    		 -23.77M -16.3M -32.5M -25.74M
    EBIT
    		 -30.62M -19.1M -34.56M -25.58M
    Depreciation & Amortization
    		 n/a 2.8M 2.07M 469.8K

    Add to Watchlist